Healthcare provider profile · identity verified

April K May, ARNP

Nurse Practitioner · YAKIMA, WA · NPI 1962953091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	85
Levothyroxine Sodium	Levothyroxine Sodium	371	64
Potassium Chloride	Potassium Chloride	288	54
Sertraline Hcl	Sertraline Hcl	285	54
Lisinopril	Lisinopril	270	49
Furosemide	Furosemide	269	51
Amlodipine Besylate	Amlodipine Besylate	259	48
Quetiapine Fumarate	Quetiapine Fumarate	254	38
Losartan Potassium	Losartan Potassium	245	41
Metoprolol Succinate	Metoprolol Succinate	214	47
Donepezil Hcl	Donepezil Hcl	206	32
Gabapentin	Gabapentin	201	37
Eliquis	Apixaban	169	33
Trazodone Hcl	Trazodone Hcl	162	27
Memantine Hcl	Memantine Hcl	158	23
Omeprazole	Omeprazole	151	27
Citalopram Hbr	Citalopram Hydrobromide	135	17
Pantoprazole Sodium	Pantoprazole Sodium	124	22
Tamsulosin Hcl	Tamsulosin Hcl	112	23
Metoprolol Tartrate	Metoprolol Tartrate	108	23
Mirtazapine	Mirtazapine	105	23
Fluticasone Propionate	Fluticasone Propionate	96	23
Oxycodone Hcl	Oxycodone Hcl	96	37
Metformin Hcl	Metformin Hcl	91	17
Simvastatin	Simvastatin	87	15
Tramadol Hcl	Tramadol Hcl	81	29
Famotidine	Famotidine	77	13
Buspirone Hcl	Buspirone Hcl	75	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	73	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	62	16
Baclofen	Baclofen	61	14
Duloxetine Hcl	Duloxetine Hcl	60	suppressed
Clopidogrel	Clopidogrel Bisulfate	58	13
Finasteride	Finasteride	57	suppressed
Pregabalin	Pregabalin	51	12
Montelukast Sodium	Montelukast Sodium	49	suppressed
Olanzapine	Olanzapine	48	suppressed
Allopurinol	Allopurinol	46	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	21
Cephalexin	Cephalexin	41	23
Latanoprost	Latanoprost	40	suppressed
Levetiracetam	Levetiracetam	40	suppressed
Divalproex Sodium	Divalproex Sodium	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Atenolol	Atenolol	38	suppressed
Fentanyl	Fentanyl	38	11
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	15
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	17
Vitamin D2	Ergocalciferol (Vitamin D2)	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Tiotropium Bromide	Tiotropium Bromide	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Lorazepam	Lorazepam	22	14
Lumigan	Bimatoprost	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Topiramate	Topiramate	21	suppressed
Azithromycin	Azithromycin	20	19
Myrbetriq	Mirabegron	20	suppressed
Risperidone	Risperidone	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Rivastigmine	Rivastigmine Tartrate	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Naproxen	Naproxen	18	suppressed
Prednisone	Prednisone	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Verapamil Hcl	Verapamil Hcl	15	suppressed
Xtampza Er	Oxycodone Myristate	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Digoxin	Digoxin	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lactulose	Lactulose	13	suppressed
Methimazole	Methimazole	13	suppressed
Ondansetron Odt	Ondansetron	13	12
Phenytoin	Phenytoin	13	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nifedipine	Nifedipine	12	suppressed
Ramipril	Ramipril	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Glipizide	Glipizide	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error